Cytovation (private company)

See something wrong or missing? Let us know
Offices:
Bergen
Business model:
B2B

Total investments received (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Cytovation was founded in 2001 with strong ties to important scientific research groups at Haukeland University Hospital and the University of Bergen. The company is currently developing CyPep-1 for the treatment of benign skin tumours including cutaneous warts and is poised to begin toxicology studies in Q4 2016.

The company’s founders are well-renowned experts in their fields and the authors of an extensive number of scientific publications.

Companies with similar profile to Cytovation:

CompanyCriteria
Sweden Scandinavian Real Hearts
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden Athera
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Denmark Oncology Venture
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Finland Mobidiag
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Iceland Key Natura
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden Monocl
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Denmark Antag Therapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden Merozyne Therapeutics
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Finland Optomed
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Finland TILT Biotherapeutics
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Norway OncoImmunity
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Sweden Elypta
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Sweden BoneSupport
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Norway Oncoinvent
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Sweden Ilya Pharma
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Finland Sooma Medical
34%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
Sweden Scint-X
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Denmark Neurescue
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Finland The Meal Planner
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD
Sweden Avidicare
33%
  • Similar verticals: Health services
  • Similar business models: B2B
  • Total raised in a similar range: 1M - 5M USD